Russell H. Wiesner, Michael K. Porayko, E. Rolland Dickson, Gregory J. Gores, Nicholas F. Larusso, J. Eileen Hay, H. Erik Wahlstrom, Ruud A. F. Krom – 1 November 1992
Eugene R. Schiff – 1 November 1992
Henry C. Bodenheimer – 1 November 1992
Yoshihide Ishiki, Hiroo Ohnishi, Yasutoshi Muto, Kunio Matsumoto, Toshikazu Nakamura – 1 November 1992 – Hepatocyte growth factor, a potent mitogen for mature hepatocytes in vitro, seems to function as a hepatotrophic factor for liver regeneration. We examined the mitogenic effect of hepatocyte growth factor on mouse liver in vivo.
Antonio Francavilla, Alessandro Azzarone, Guiseppe Carrieri, Carlo Scotti‐Fogueni, Qia‐Hua Zeng, Umberto Cillo, Kendrick Porter, Thomas E. Starzl – 1 November 1992 – Transforming growth factor‐β canceled the hepatocyte proliferation caused by transforming growth factor‐α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula.
Pierre Laurent‐Puig, Jean‐François Flejou, Monique Fabre, Pierre Bedossa, Jacques Belghiti, François Gayral, Dominique Franco – 1 November 1992 – Mutant p53 has been found in a wide variety of human malignancies including carcinomas of the lung, breast and colon.
Philippe Sogni, Richard Moreau, Masaru Ohsuga, Stephane Cailmail, Frederic Oberti, Antoine Hadengue, Eric Pussard, Didier Lebrec – 1 October 1992 – Because it has been hypothesized that the hyperkinetic circulation in portal hypertension is the result of increased synthesis of nitric oxide, we compared the hemodynamic effects of nitric oxide synthesis—specific agonist (L‐arginine) and antagonist between normal and cirrhotic conscious rats. The dose‐response curves showed that L‐arginine significantly decreased arterial pressure and increased heart rate.
Tomihiro Hayakawa, Kenji Katagiri, Makoto Hoshino, Tomio Nakai, Takayuki Ohiwa, Tomoyuki Kumai, Makoto Miyaji, Toshihiko Takeuchi, James Corasanti, James L. Boyer – 1 October 1992 – Papaverine is a nonspecific smooth muscle relaxant and a phosphodiesterase inhibitor. Its effects on biliary excretion of lipids and horseradish peroxidase were investigated in a single‐pass isolated perfused rat liver model. A constant infusion of papaverine (1.6 μmol/min; 40 μmol/L) significantly increased bile flow (microliters per minute per gram of liver) before (2.03 ± 0.09 vs.
1 October 1992